LTRN
Lantern Pharma·NASDAQ
--
--(--)
--
--(--)
LTRN fundamentals
Lantern Pharma (LTRN) expects to report earnings on Mar 30, 2026, with estimated revenue of 0 (YoY --), and EPS at -0.46 (YoY +14.81%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-0.46
+14.81%
Report date
Mar 30, 2026
Earnings Call
4:30 PM on Mar 30, 2026
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Lantern Pharma (LTRN) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Lantern Pharma (LTRN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Lantern Pharma (LTRN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Lantern Pharma (LTRN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Lantern Pharma (LTRN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Lantern Pharma (LTRN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Lantern Pharma's management provide for the next earnings period?What is the revenue and EPS growth rate for Lantern Pharma year over year?What does Lantern Pharma do and what are its main business segments?What were the key takeaways from Lantern Pharma’s earnings call?What were the key takeaways from Lantern Pharma's earnings call?What is the market's earnings forecast for Lantern Pharma next quarter?What is Lantern Pharma's gross profit margin?What factors drove the changes in Lantern Pharma's revenue and profit?
